Research reveals rise in AFib among younger people. Learn the warning signs, risk factors and how to protect your heart ...

Recent research shows the incredible success of radiofrequency ablation in treating AFib, offering renewed hope for patients.

During a fireside chat at the annual J.P. Morgan Healthcare Conference on January 13th, Mayo Clinic chief administrative ...

Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look at where AtriCure, Inc. (NASDAQ:ATRC) stands against the other stocks that ...

For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor ...

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

Cedars-Sinai shared the story of a Hollywood writer who kept his appointment for mitral valve surgery right after escaping ...

The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation system in a larger group of patients with atrial fibrillation.

General Hospital spoilers and updates for the week of Monday, January 20-Friday, January 24 tease questions, anger, and collapse! Anna Devane (Finola Hughes) has serious questions, Carly Spencer ...

From medical B2B sales to jewelry stores, smart rings may find new avenues to attracting consumer interest beyond the niche ...

The Circular Ring 2 features an AFib detection system that should greatly help the device find its space in the smart ring ...